Trials / Unknown
UnknownNCT03303222
Study to Develop a Breath Analyser to Detect Chronic Kidney Disease
Pilot Study to Develop a Breath Analyser to Detect Chronic Kidney Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University College, London · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Measure trimethylamine oxide in the breath.
Detailed description
Organic compounds such as trimethylamine oxide (TMAO) accumulate in the blood of patients with kidney disease, and volatile compounds such as TMAO can be detected in the breath. The investigators wish to develop a breath analyser to measure volatile compounds, such as TMAO in the breath in patients with kidney disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | breath | measurement of volatile compounds, such as TMAO in exhaled breath and blood |
Timeline
- Start date
- 2021-02-10
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2017-10-05
- Last updated
- 2020-11-04
Source: ClinicalTrials.gov record NCT03303222. Inclusion in this directory is not an endorsement.